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ABSTRACT 
 
 
 
 
In drug-delivery systems, the drug carriers should meet several prerequisites 
such as biocompatibility, biodegradability and lack of immune system activation, in 
order to play an effective role. In this study, a comprehensive attempt has been 
carried out to investigate the plausible intermolecular interactions of new drug-
delivery systems, by correlating the drug release kinetic with the different types of 
carriers used. A hydrophilic metal oxide, silica (SiO2), was used as the inorganic 
carrier, while poly(lactide-co-glycolide) (PLGA), a hydrophobic polyester, was used 
as the organic carrier. Based on these materials, the designed drug-delivery systems 
were SiO2/albumin/curcumin (SiO2/Alb/Cur) and PLGA/albumin/curcumin 
(PLGA/Alb/Cur), where albumin was used as the co-carrier, while curcumin as the 
hydrophobic model drug. The release of curcumin was proved to be controlled by the 
addition of albumin in the systems. It was expected that by using different kinds of 
carriers, different drug release patterns will be obtained, since the properties of the 
carriers can then influence the intermolecular interactions within the systems. Thus, 
the study of the intermolecular interaction of SiO2/Alb/Cur systems was carried out 
by varying SiO2 and albumin composition, and using different sources of SiO2. 
Besides that, the study of the intermolecular interaction of PLGA/Alb/Cur was also 
done using different pretreatment methods and dispersion media of PLGA. The 
release experiments of albumin and curcumin were conducted via in-vitro procedures 
and phosphate buffer solution (pH 7) was used as the medium. The amounts of 
albumin and curcumin desorbed from the systems at different time intervals were 
monitored by UV-Visible spectroscopy (UV-Vis). The samples were characterized 
using diffuse reflectance UV-visible (DR-UV) spectroscopy, Fourier transform 
infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), scanning electron 
microscopy (SEM), specific surface area analysis and differential scanning 
calorimetry (DSC). The in-vitro studies show that the release of albumin and 
curcumin from SiO2/Alb/Cur system is dependent on the compositions of SiO2 and 
albumin, and the source of SiO2 used (tetraethoxysilane (TEOS) and fumed silica). 
The release of albumin and curcumin was correlated with the intermolecular 
interaction between SiO2, albumin, and curcumin. The addition of albumin as the co-
carrier caused an increase in the total cumulative release amount of curcumin, 
suggesting that there was a competition between albumin and curcumin to interact 
with either SiO2 or PLGA. Here, it was demonstrated that the amount of curcumin 
released was strongly affected by the carriers used. The use of SiO2 as the carrier 
showed that release of curcumin followed pseudo-second order kinetics, while the 
use of PLGA showed a first-order kinetic at 49 h. It is concluded that a sustained and 
controlled drug release system can be achieved by using SiO2 as the carrier. The 
different strategies and intermolecular interactions described here may be useful in 
designing a sustainable and controlled drug release system that can meet the medical 
demands of pharmaceutical applications.  
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ABSTRAK 
 
 
 
 
Dalam sistem penghantaran dadah, sesuatu pembawa dadah mesti memenuhi 
beberapa prasyarat seperti biodegradasi, bioserasi dan mempunyai kadar pengaktifan 
sistem imun yang rendah, bagi membolehkannnya memainkan peranan yang efektif. 
Dalam kajian ini, satu percubaan komprehensif telah dijalankan untuk mengkaji 
interaksi antara molekul yang berkemungkinan dalam sistem penghantaran dadah 
baru, dengan menghubungkaitkan kinetik pelepasan dadah dengan pelbagai jenis 
pembawa. Oksida logam hidrofilik, silika, digunakan sebagai pembawa tak organik, 
manakala poliester hidrofobik, poli(laktida-ko-glikolida) (PLGA) digunakan sebagai 
pembawa organik. Berdasarkan bahan ini, sistem penghantaran dadah yang dibentuk 
adalah silika/albumin/kurkumin dan PLGA/albumin/kurkumin, dengan albumin 
digunakan sebagai ko-pembawa, manakala kurkumin sebagai model dadah 
hidrofobik. Pelepasan kurkumin telah dibuktikan dapat dikawal dengan penambahan 
albumin kepada sistem. Adalah dijangkakan dengan menggunakan pembawa yang 
berlainan, pola pelepasan dadah yang berlainan akan diperoleh kerana sifat pembawa 
boleh mempengaruhi interaksi antara molekul dalam sistem. Oleh itu, kajian 
interaksi antara molekul untuk sistem SiO2/Alb/Cur telah dijalankan dengan pelbagai 
komposisi SiO2 dan albumin, dan sumber SiO2 yang berlainan. Selain itu, kajian 
interaksi antara molekul dalam sistem PLGA/Alb/Cur telah dilakukan dengan 
menggunakan kaedah prarawatan dan medium penyebaran PLGA yang berbeza. 
Eksperimen pelepasan albumin dan kurkumin telah dijalankan melalui prosedur in 
vitro dan larutan penimbal fosfat (pH 7) digunakan sebagai medium. Jumlah albumin 
dan kurkumin yang ternyahjerap daripada sistem dipantau pada selang masa berbeza 
menggunakan spektroskopi ultralembayung-nampak. Sampel telah dicirikan 
menggunakan spektroskopi ultralembayung-nampak pantulan terbaur, spektroskopi 
inframerah transformasi Fourier, analisis termogravimetri, mikroskop imbasan 
elektron, analisis luas permukaan spesifik dan kalorimetri pembezaan pengimbasan. 
Kajian in-vitro menunjukkan pelepasan albumin dan kurkumin daripada sistem 
SiO2/Alb/Cur bergantung kepada komposisi SiO2 dan albumin, dan sumber SiO2 
yang digunakan (tetraetoksisilana dan wasap silika). Pelepasan albumin dan 
kurkumin kemudiannya dikorelasikan dengan interaksi molekul antara SiO2, 
albumin, dan kurkumin. Penambahan albumin sebagai ko-pembawa menyebabkan 
peningkatan jumlah pelepasan kumulatif untuk kurkumin, yang mencadangkan 
persaingan antara albumin dan kurkumin berinteraksi dengan SiO2 atau PLGA. Telah 
ditunjukkan bahawa jumlah pelepasan kurkumin amat dipengaruhi oleh pembawa. 
Penggunaan SiO2 sebagai pembawa menunjukkan pelepasan kurkumin mengikut 
kinetik tertib pseudo-kedua, manakala penggunaan PLGA menunjukkan kinetik 
tertib pertama pada 49 jam. Kesimpulannya, sistem penghantaran dadah terkawal dan 
beransur dapat dicapai dengan menggunakan SiO2 sebagai pembawa. Strategi 
berbeza dan interaksi molekul yang diterangkan berkemungkinan boleh digunakan 
dalam mereka bentuk sistem pelepasan dadah terkawal dan beransur yang memenuhi 
permintaan perubatan untuk kegunaan farmaseutikal. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Research Background 
 
 
Over the past few decades, there has been a significant growth in the drug-
delivery field due to the underlying principle that drug-delivery technology could 
carry both therapeutic and commercial values to the health care products (Ahmadi et 
al., 2014). Furthermore, it has also been reported that drug delivery is one of the 
fastest-growing areas of the pharmaceuticals market, with approximately 10% annual 
growth and with the value of US $82 billion for the US market (Bruinewoud et al., 
2005).  It has been generally acknowledged that conventional drug-delivery system 
(DDS) is composed of a delivery device or dosage forms like a simple carrier 
without a lot of added value. Among the examples of conventional dosage forms are 
tablets or suspensions for oral administration, and solution for parental 
administration by injection (Bruinewoud et al., 2005).   
 
 
The evolvement in the drug-delivery area led to the exploration of new 
dosing routes, for instance, transdermal, vaginal, pulmonary and sublingual (Wilson 
et al., 2011). Subsequently, more new drugs appeared with higher sensitive dose 
which often have poorer stabilities in a biological environment which is reported to 
have appeared in the 1990s (Barbe et al., 2004). This issue gave a stronger push 
towards the development of more efficient encapsulation and controlled-release of 
drug administration system. Therefore, a sustained and controlled-release of a drug-
delivery system was progressively studied. 
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In the pharmaceutical industry, controlled drug-delivery systems (CDDS) 
have been widely applied as a strategic procedure to extend the specific potential of a 
drug product that reaches the human body systems (Siepmann et al., 2012). This type 
of DDS is mainly designed by researchers with the aim to deliver drugs within the 
desired range in the body continuously over a long period of time.  Prolongation of 
the drug efficacy during administration process can be established by increasing the 
stability and enhancing the drug bioavailability (Wilson et al., 2011 and Bruinewoud 
et al., 2005). As the result, the frequency of the dose administered can be decreased 
considerably. Besides that, one more advantage promoted by the sustained delivery 
formulation contrary to the conventional dosing is the ability to avoid side effects 
when the drug is administered repeatedly (Zharapova et al., 2012). The examples of 
conventional drug dosing and controlled drug delivery are illustrated in Figure 1.1. 
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Figure 1.1: Conventional dosing versus sustained drug-delivery (Bruinewoud et al., 
2005) 
 
 
Therefore, it can be concluded that the foremost aim of a sustained and 
controlled-delivery system, is to design and control the drug releases at a specific 
rate over a defined period of time with minimal harm to the patient while improving 
human health (Bruinewoud et al., 2005 and Siepmann et al., 2012). Various aspects 
of a drug carrier need to be taken into account in order to play an effective role.  The 
3 
carrier should satisfy several perquisites such an excellent biocompatibility, 
biodegradable to human system and lack of immune system activation (Wang, 2009, 
Ahmadi et al., 2014 and Horjacada et al., 2006). 
 
 
On the other hand, numerous materials have been designed by the researchers 
to build up framework purposely for CDDS. Up until now, the drug-delivery system 
is designed according to the three kinds of carrier; inorganic, organic and inorganic-
organic composite. Metal oxides such as silica (SiO2) and titania (TiO2) have been 
frequently employed as for inorganic-based drug-delivery system. In the case of the 
organic-based system, a wide range of biodegradable materials including natural and 
synthetic polymers have been utilized in the previous researches. Apart from that, the 
composite of inorganic and organic carriers is has also gained attention in the drug-
delivery field. Table 1.1 summarizes the materials that have been used as drug 
carriers. 
 
 
Table 1.1: Inorganic, organic and inorganic-organic drug carriers 
Drug-delivery systems Drugs Ref. 
Inorganic-carriers   
Calcium carbonate microcapsules Lysozyme Fujiwara et al., (2008) 
Nanoporous TiO2 matrices Ibuprofen Signoretto et al., (2011) 
Mesoporous SiO2 (SBA-15) Ibuprofen Ahmadi et al., (2014) 
Mesoporous SiO2 nanoparticles 
(MCM-41) 
Ibuprofen and 
atenolol 
Steven et al., (2014) 
Organic-carriers   
Human Serum Albumin Curcumin Sahoo et al., (2008) 
PLGA nanoparticles Quercetin and 
catechin 
Pool et al., (2012) 
 
Hydroxypropylmethylcellulose 
(HPMC) matrix 
Melatonin Lee et al., (1999) 
 
Polyvinyl acetate Losartan 
potassium 
Sarwar et al., (2012) 
   
Continue on next page 
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Dendrimers Artemether, 
camptothecin, 
cisplatin 
Svenson et al., (2009) 
Bovine Serum Albumin Curcumin Sadeghi et al., (2014) 
Inorganic-organic composites   
Mesoporous SiO2 (MCM)/apatite 
nanocomposite 
Atenolol Souza et al., (2008) 
Chitosan coated mesoporous SiO2 
(MCM) nanoparticles 
Ibuprofen Popat et al., (2012) 
 
 
Our study here focuses on the utilization of SiO2 as an inorganic-based while 
Poly(lactide-co-glycolide) (PLGA) was employed as organic-based. SiO2 is 
intrinsically hydrophilic metal oxide due to the presence of hydroxyl group on its 
surface (Horjacada et al., 2006). This natural hydrophilic character avoids 
elimination of SiO2 by the reticuloendothelial system (RES). Specifically, RES is an 
immune system that works to evacuate any foreign entities from the body once it gets 
detected (Barbe et al., 2004). Therefore, tailoring SiO2 as a carrier for the drug-
delivery system can enhance circulation time of drug in blood stream. Amorphous 
SiO2 is used in numerous applications such as in implant or coating relying on its 
biocompatibility aspect (Barbe et al., 2004). Besides that, it is a non-toxic material 
and has been used in food additives or vitamin supplements (Gangwar et al., 2013). 
Figure 1.2 illustrates SiO2 particle decorated with hydroxyl surface. 
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Figure 1.2: SiO2 with hydroxyl surfaces 
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PLGA is relatively hydrophobic polyester which consists of hydroxyl-end 
group in the structure (Erbetta et al., 2012). It is built up by the subunit of lactic and 
glycolic acids, where these acids can be eliminated from the body as carbon dioxide 
and water through the tricarboxylic acid cycle (Cheng et al., 2008 and Gentile et al., 
2014). One of the interesting aspects of PLGA is that the degree of hydrophobicity of 
PLGA can be tuned by varying the ratio of lactide to glycolide. The selection of the 
required ratio is important as this can strongly influence the physiochemical 
characteristics of the end-product and the dissolution of the drug. Figure 1.3 displays 
the chemical structure of PLGA and its monomer. Apart from that, the biodegradable 
character of PLGA is explained by the hydrolysis of its ester linkages in water 
(Makadia et al., 2011). PLGA is utilized in delivery system and bone tissue 
engineering applications because it is less toxic and biocompatible (Cheng et al., 
2008 and Gentile et al., 2014). Incorporation of hydrophobic drug in PLGA particles 
increases circulation of material in blood stream. Various techniques have been 
employed to prepare PLGA nanoparticles such as emulsification-evaporation, 
emulsion-diffusion, salting-out, and precipitation (Song et al., 2006). Besides that, 
different types of solvent used in the dispersion of PLGA crystal, resulting in 
particular particle sizes of PLGA particle (Song et al., 2006). 
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Figure 1.3: Chemical structure of PLGA and its monomers (Gentile et al., 2014) 
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In addition, we also intend to explore the functionality of albumin, the 
common component in a drug-delivery system, as co-carrier to control the release of 
the drug. It has been reported that the use of the protein as a drug-carrier does not 
affect the properties of the associated drug (Elzoghby et al., 2012 and Thomas et al., 
2014). Here, egg white protein or ovalbumin is used as the source of albumin. 
Ovalbumin consists of 385 amino acid residues with a molecular weight of 47 kDa. It 
has an internal disulfide bond and four free sulphydryl groups (Elzoghby et al., 2012 
and Huntington et al., 2001). Its tertiary structure was composed of nine α-helices 
and three β-sheets that folded into a compact globule supported mainly by the 
hydrogen bonds and disulfide bonds (Leunissen, 2001 and Bhattacharya et al., 2012). 
Albumin can enhance the apparent solubility of hydrophobic drug (Mohanta et al., 
2013). Drugs could bind into the hydrophobic pocket of albumin via hydrophobic or 
van der Waals interactions. The presence of numerous functional groups in protein 
residues provides feasibility of drug-albumin interaction.  
 
 
In this research, curcumin was used as the hydrophobic drug model. 
Curcumin, or diferuloylmethane, is a natural component of the rhizome of turmeric 
(Curcuma longa). Numerous studies on using curcumin as a therapeutic agent have 
been carried out due to its anti-oxidant, anti-inflammatory, anti-carcinogenic and 
anti-bacterial properties (Chereddy et al., 2013, Gangwar et al., 2013, Hatamie et al., 
2012, Jithan et al., 2011 and Mathew et al., 2012). The anti-oxidant property of 
curcumin is contributed to the presence of phenolic –OH and β-diketone moiety that 
have the ability to scavenge the molecular species of active oxygen. Its hydrophobic 
nature and poor bioavailability leads to poor activity, low absorption, high rate of 
metabolism within the living system and rapid elimination from the body system. 
Curcumin undergoes rapid degradation in pH 7.4 buffer solution, where it is 
degraded more than 50% in 30 min release period (Leung et al., 2015). Therefore, 
there is a need for extensive research on this matter, which do not only improve the 
bioavailability of curcumin by increasing its solubility, but also to keep the 
multifunctional properties of the conjugated system. Figure 1.4 shows the chemical 
structure of curcumin with the presence of phenolic –OH and β-diketone moiety.  
 
7 
                 
 
 
 
 
                 
O OH
OH
H3CO OCH3
OH
Phenolic –OH  
β-diketone moiety 
 
 
 
Figure 1.4: Chemical structure of curcumin (Leung et al., 2015)  
 
 
The corresponding drug-delivery systems that were designed here are 
SiO2/albumin/curcumin (SiO2/Alb/Cur) and PLGA/albumin/curcumin 
(PLGA/Alb/Cur), where SiO2 act as the inorganic carrier while PLGA is the organic 
carrier. It is interesting to note that the release trend of the drug can be affected by 
the type of carriers. In other words, the dissolution of the drug can be controlled 
depending on the carrier employed due to the particular intermolecular interaction 
within the system. Therefore, it can be summarized generally that the drug release 
from the system is correlated to the specific intermolecular interaction within the 
system and the type of carrier used. The presence of albumin as a co-carrier can 
provide in new role in term of intermolecular interaction in the drug-delivery system. 
It is realized that curcumin release can be controlled due to the existence of albumin 
in the system. Moreover, it has been demonstrated that conjugation of curcumin to 
albumin has increased its bioavailability characteristic (Thomas et al., 2014). 
Subsequently, the system designed here could be a promising drug-delivery system 
that related to the administration of hydrophobic pharmaceutical compound.  
 
 
 
 
1.2 Statement of Problem 
 
  
 Generally, drug release is a process where a drug or any pharmaceutical 
compound is detached from its carrier, and then is associated to the absorption, 
distribution, metabolism and excretion (Singhvi et al., 2011). Significant efforts and 
advances in biotechnology have facilitated the production of new pharmaceutical 
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compounds. Hence, various drug-delivery systems or vehicles for the delivery of 
drug have been developed to satisfy the ever-growing demand for prolonged and 
better control of the drug administration. As a consequence, the controlled-released 
systems have been progressively conducted in the last few decades with the 
following objectives (Siepmann et al., 2012): 
 to improve the appearance or enhance the circulation time of drug in the body 
 to avoid elimination drug by RES system 
 to improve the quality control in the production of drug products  
 
 
 In the past few years, there are numerous drug-delivery systems that have 
been designed in the administration of curcumin due to its favorable advantages in 
clinical aspects. Curcumin has been used as the remedy for some illness, for instance, 
inflammation and breast cancer. In conjunction with that, there are different 
formulations that have been studied such as PLGA loaded curcumin (Chereddy et al., 
2013), albuminated curcumin (Thomas et al., 2014) and curcumin attached to the 
SiO2 carrier (Gangwar et al., 2013).  
 
 
  However, these studies are more focused on the curcumin’s solubility 
properties from the different formulation. To the best of our knowledge, a 
comprehensive study on controlled-released of curcumin from different kinds of 
carrier was less reported. Therefore, this study aims to design new drug-delivery 
systems that comprising both inorganic and organic material as the system-based 
with a co-carrier in the system. The novelty of the study can be related to the 
development of the new drug-delivery systems which are SiO2/albumin/curcumin 
and PLGA/albumin/curcumin systems. Besides that, we also focused on the 
relationship between the drug release kinetic towards the particular intermolecular 
interactions exhibited by the drug-delivery systems with respects to SiO2 and PLGA 
as system-based.  
 
 
By using two different kinds of carriers, SiO2 and PLGA in our case, it was 
expected that the drug release pattern could be different owing to the different 
characteristic of the carrier used. The hydrophilic character of SiO2, due to its 
hydroxyl surface, can improve the solubility of curcumin and directly increase the 
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bioavailability in the clinical application. PLGA, on the other hand, is a hydrophobic 
polymer with the hydroxyl-end. Incorporation of curcumin within the PLGA matrix 
may prolong the circulation times in blood stream. The biocompability character of 
SiO2 and the biodegradability property of PLGA towards the body system promote a 
safe and reliable drug-delivery system. It can be suggested that the properties of 
carrier may influence the release pattern of the drug, since the release mechanism 
between them is governed by its specific intermolecular interaction between the drug 
and the carrier. In a simple way, the property of the carrier itself affects the release 
mechanism of drug. In general, the interactions of a drug with carrier are associated 
through the hydrogen bond, hydrophilic and hydrophobic interactions, and Van der 
Waals force.  
 
 
 Figures 1.5 summarizes the schematic of the research approach and research 
questions in this study. In the inorganic-based system, SiO2 particle was prepared 
using Stöber method prior to the addition of albumin and curcumin. The precursor of 
SiO2 here was tetraethoxysilane (TEOS). The intermolecular interactions of the 
SiO2/Alb/Cur systems were studied by varying the composition of SiO2 and albumin, 
and using other type of SiO2 which was fumed silica. For the preparation of PLGA-
based systems, the intermolecular interaction of PLGA/Alb/Cur systems were 
explored by focusing on the different pre-treatment methods and different dispersion 
solvents of PLGA. The pre-treatment methods of PLGA were done by the addition of 
methyl methacrylate (MMA), and the addition of MMA followed by the irradiation 
under UV light. The pre-treatment procedures engaged here were purposely to 
modify the molecular structural of PLGA, which was theoretically, could promotes a 
good intermolecular interaction within the system. Moreover, the pre-treatment step 
proposed here reflects the novelty of PLGA that was used as a carrier for 
incorporation of drug. Most of the previous studies were using PLGA as the 
nanoparticles to encapsulate the associated drug (Akl et al., 2016, Dinda et al., 2011, 
Manoochehri et al., 2013 and Luz et al., 2012) 
 
 
 The engagement of albumin in the systems is expected to control the drug 
release. It has been reported that albumin may enhance the solubility of curcumin 
(Mohanta et al., 2013). Therefore, the utilization of albumin may increase the 
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bioavailability characteristic of curcumin which is beneficial in the clinical field. 
Besides that, it is also biocompatible material and widely abundance in nature (Li et 
al., 2009).  
 
 
Preparation of SiO2/Alb/Cur and PLGA/Alb/Cur systems present a new 
approach in developing a new controlled-release drug-delivery system. The crucial 
parts here were the comprehensive attempt to investigate the correlation between the 
drug releases from the designed drug-delivery systems towards its specific 
intermolecular interactions due to the different kind of carriers used. The release of 
curcumin together with albumin was explored in order to examine the effects of 
different parameters applied (SiO2/Alb/Cur systems) and dissimilar preparation 
procedures and solvent used (PLGA/Alb/Cur systems). It is hypothesized that the 
release of curcumin and albumin from the carriers were strongly correlated with the 
intermolecular interactions within SiO2/Alb/Cur and PLGA/Alb/Cur systems.  Based 
on the above considerations, statement of the problem can be defined as follows: 
Release of curcumin can be controlled in the SiO2- and PLGA-based systems with 
albumin as the co-carrier. 
 
 
 This study proposed a new drug-delivery system involving controlled-release 
of drug in both inorganic and organic-based DDS. The impact of the engagement of 
albumin in the systems can influence the detachment of curcumin from SiO2 and 
PLGA carrier. Besides that, the intermolecular interaction aspects on each system 
will be clarified in this study. This new design of DDS is expected to show 
pronounced advantages as a drug carrier in the administration of a hydrophobic 
compound (curcumin). A detailed exploration through this study will yield a 
fundamental understanding as well as the new intermolecular interaction between 
drug and carriers. 
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Research Questions 
 What are the effects of SiO2 and PLGA that act as the 
inorganic and organic-based in the drug-delivery systems?  
 What are the effects of albumin as the co-carrier in 
the drug-delivery systems? 
 What are the physiochemical properties of the drug-
delivery systems obtained? 
 What are the intermolecular interactions that 
influence the drug-delivery systems? 
 
Controlled-release of curcumin from  
Poly(lactide-co-glycolide)/Albumin/Curcumin and 
Silica/Albumin/Curcumin drug-delivery system 
SiO2/albumin/curcumin PLGA/albumin/curcumin 
Experimental 
The study of the 
intermolecular interaction of 
SiO2/albumin/curcumin with 
the variation of SiO2 and 
albumin compositions, and 
sources of SiO2 carrier 
 
 
The study of intermolecular 
interaction of 
PLGA/albumin/curcumin with 
different pre-treatment 
methods of PLGA and 
dispersion media for PLGA 
 
 
 
Release studies of albumin and curcumin  
 
 
 
Figure 1.5: The schematic of the research approach and research questions 
 
 
 
 
1.3 Objectives of Study 
 
 
The ultimate goal of the present work is to design and prepare new drug-
delivery systems that could achieve a controlled drug-delivery system (see Figure 
1.1). The novelty of the work lies partly in the preparation of novel drug-delivery 
systems by using inorganic and organic materials as the system carrier. Besides that, 
the release kinetic of the albumin and curcumin are studied in order to elucidate the 
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mechanism of drug release. Therefore, this study has been carried out with the 
following objectives:     
 
 To prepare and characterize inorganic and organic-based drug-delivery 
systems, SiO2/Alb/Cur and PLGA/Alb/Cur.   
 To evaluate the performance of the drug-delivery systems by carrying out 
release experiments of SiO2/Alb/Cur and PLGA/Alb/Cur sytems. 
 To investigate the intermolecular interaction between these two kinds of 
inorganic and organic carriers, which are SiO2 and PLGA, with albumin as 
the co-carrier. 
 
 
 
 
1.4 Thesis Outline 
 
 
 This thesis comprises of five chapters and the outlines of each chapter are as 
follows. Chapter 1 contains an introduction of research background on the drug-
delivery field followed by the research’s problem statement. The objectives, scope 
and the significance of the present study are described in this chapter. Chapter 2 
comprises of literature reviews that are related to this study. Chapter 3 discusses the 
experimental and characterization methods of both systems. Chapter 4 contains the 
characterization outcomes, release performance results and kinetics study of the 
SiO2/Alb/Cur system while Chapter 5 contains the similar outlines for 
PLGA/Alb/Cur system including the comparative studies of both of the systems. 
Chapter 6 discussed a concise conclusion based on the research findings and the 
recommendations for future study.  
 
 
 
 
1.5 Scope of the Study 
 
 
This study aims to develop a new drug-delivery system using SiO2 and PLGA 
as the inorganic- and organic-based illustrated in the Figures 1.2 and 1.3. In the first 
system, the interaction between the albumin with the SiO2 carrier was studied. Three 
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different SiO2/albumin materials were prepared by dissimilar approaches; fumed 
silica/albumin (FS/Alb), fumed silica/albumin treated with NaBH4 (FS/Alb-N) and 
SiO2 sol from TEOS/Albumin (SS/Alb). Albumin release was carried out by the in-
vitro method in phosphate buffer solution (PBS) at pH 7 and the amount of albumin 
desorbed from SiO2 was detected by using UV-Visible (UV-Vis) spectrometer. 
Based on the characterization and cumulative release findings of SiO2/albumin 
samples, the study was further carried out by using SiO2 sol from TEOS as the SiO2 
precursor for all prepared SiO2/Alb/Cur systems. There were three different 
parameters engaged in the SiO2/Alb/Cur systems; different SiO2/albumin 
composition, different albumin composition and the use of fumed silica as the SiO2 
source. Release of both albumin and curcumin were detected by UV-Vis. In order to 
determine the influence of albumin to the release of curcumin from SiO2/Alb/Cur 
system, one sample consisting of SiO2 and curcumin was prepared. The kinetic 
release orders are clarified accordingly. The obtained materials were characterized by 
diffuse reflectance UV-Visible (DR UV-Vis) spectrometer, Fourier transform 
infrared (FTIR) spectrometer, thermogravimetric analysis (TGA), Specific Surface 
Area (BET) Analysis, and scanning electron microscopy (SEM).  
 
 
Apart from that, there were two approaches in the PLGA/Alb/Cur system. 
Firstly, this kind of system was prepared in two pre-treatment steps; PLGA added 
with methyl methacrylate and PLGA added with methyl methacrylate and followed 
by exposure to UV irradiation. Secondly, PLGA/Alb/Cur systems were prepared by 
using two different solvents for the dispersion of the PLGA polymer. The solvents 
were acetone and ethyl acetate. PLGA/Cur sample was prepared with the purpose to 
identify the impact of albumin present in the PLGA/Alb/Cur system. The obtained 
materials were also characterized by FTIR, DRUV, TGA, differential scanning 
calorimetry (DSC), BET and SEM. Release of both albumin and curcumin were 
detected by DRUV-Vis. Figure 1.6 summarizes concisely the scope of this research. 
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Figure 1.6: Diagram representation of scope of the study 
 
 
 
 
1.6 Significance of the Study 
 
 
This research comprehensively investigates the intermolecular interaction of 
new drug-delivery systems by correlating the drug release kinetics towards the 
different types of carriers. It would significantly contribute to the knowledge of 
controlled drug release and would be useful to the pharmaceutical industry in the 
future. Besides that, the new drug-delivery systems prepared here can be a potential 
system in the administration of other hydrophobic pharmaceutical compound in the 
future. 
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